USANA HEALTH SCIENCES INC Quarterly Income Tax Expense (Benefit) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Usana Health Sciences Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q2 2024.
  • Usana Health Sciences Inc Income Tax Expense (Benefit) for the quarter ending June 29, 2024 was $9.77M, a 2.66% increase year-over-year.
  • Usana Health Sciences Inc Income Tax Expense (Benefit) for the twelve months ending June 29, 2024 was $39.4M, a 3.79% increase year-over-year.
  • Usana Health Sciences Inc annual Income Tax Expense (Benefit) for 2023 was $38.7M, a 1.54% decline from 2022.
  • Usana Health Sciences Inc annual Income Tax Expense (Benefit) for 2022 was $39.3M, a 27.5% decline from 2021.
  • Usana Health Sciences Inc annual Income Tax Expense (Benefit) for 2021 was $54.1M, a 1.6% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $39.4M $9.77M +$253K +2.66% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-06
Q1 2024 $39.1M $10.6M +$456K +4.51% Dec 31, 2023 Mar 30, 2024 10-Q 2024-05-07
Q4 2023 $38.7M $9.85M -$162K -1.62% Oct 1, 2023 Dec 30, 2023 10-K 2024-02-27
Q3 2023 $38.8M $9.18M +$889K +10.7% Jul 2, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $37.9M $9.52M -$633K -6.24% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-06
Q1 2023 $38.6M $10.1M -$700K -6.47% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-07
Q4 2022 $39.3M $10M -$1.32M -11.6% Oct 2, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $40.6M $8.3M -$4.73M -36.3% Jul 3, 2022 Oct 1, 2022 10-Q 2023-11-07
Q2 2022 $45.3M $10.2M -$5.93M -36.9% Apr 3, 2022 Jul 2, 2022 10-Q 2023-08-08
Q1 2022 $51.2M $10.8M -$2.9M -21.1% Jan 2, 2022 Apr 2, 2022 10-Q 2023-05-09
Q4 2021 $54.1M $11.3M -$3.58M -24% Oct 3, 2021 Jan 1, 2022 10-K 2024-02-27
Q3 2021 $57.7M $13M -$749K -5.44% Jul 4, 2021 Oct 2, 2021 10-Q 2022-11-08
Q2 2021 $58.5M $16.1M +$4.07M +33.9% Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-09
Q1 2021 $54.4M $13.7M +$1.1M +8.75% Jan 3, 2021 Apr 3, 2021 10-Q 2022-05-11
Q4 2020 $53.3M $14.9M -$146K -0.97% Sep 27, 2020 Jan 2, 2021 10-K 2023-02-28
Q3 2020 $53.4M $13.8M +$2.1M +18% Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-10
Q2 2020 $51.3M $12M +$868K +7.8% Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-11
Q1 2020 $50.5M $12.6M +$489K +4.03% Dec 29, 2019 Mar 28, 2020 10-Q 2021-05-11
Q4 2019 $50M $15M -$2.08M -12.2% Sep 29, 2019 Dec 28, 2019 10-K 2022-03-01
Q3 2019 $52.1M $11.7M -$3.82M -24.7% Jun 30, 2019 Sep 28, 2019 10-Q 2020-11-03
Q2 2019 $55.9M $11.1M -$6.49M -36.8% Mar 31, 2019 Jun 29, 2019 10-Q 2020-08-04
Q1 2019 $62.4M $12.1M -$2.92M -19.4% Dec 30, 2018 Mar 30, 2019 10-Q 2020-05-05
Q4 2018 $65.3M $17.1M -$25.1M -59.4% Sep 30, 2018 Dec 29, 2018 10-K 2021-03-02
Q3 2018 $90.4M $15.5M +$7.21M +87.1% Jul 1, 2018 Sep 29, 2018 10-Q 2019-11-05
Q2 2018 $83.2M $17.6M +$8.05M +84.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $75.1M $15M +$3.03M +25.3% Dec 31, 2017 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $72.1M $42.2M +$32.4M +327% Oct 1, 2017 Dec 30, 2017 10-K 2020-02-25
Q3 2017 $39.8M $8.28M +$2.28M +37.9% Jul 2, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $37.5M $9.57M -$2.34M -19.6% Apr 2, 2017 Jul 1, 2017 10-Q 2018-08-08
Q1 2017 $39.8M $12M +$1.3M +12.2% Jan 1, 2017 Apr 1, 2017 10-Q 2018-05-09
Q4 2016 $38.5M $9.89M -$1.68M -14.5% Oct 2, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $40.2M $6M -$6.8M -53.1% Jul 3, 2016 Oct 1, 2016 10-Q 2017-11-08
Q2 2016 $47M $11.9M -$1.37M -10.3% Apr 3, 2016 Jul 2, 2016 10-Q 2017-08-09
Q1 2016 $48.4M $10.7M +$435K +4.23% Jan 3, 2016 Apr 2, 2016 10-Q 2017-05-10
Q4 2015 $47.9M $11.6M +$810K +7.53% Oct 4, 2015 Jan 2, 2016 10-K 2018-02-28
Q3 2015 $47.1M $12.8M +$3.34M +35.3% Jul 5, 2015 Oct 3, 2015 10-Q 2016-11-09
Q2 2015 $43.8M $13.3M +$3.19M +31.6% Apr 5, 2015 Jul 4, 2015 10-Q 2016-08-09
Q1 2015 $40.6M $10.3M +$1.56M +18% Jan 4, 2015 Apr 4, 2015 10-Q 2016-05-11
Q4 2014 $39M $10.8M +$2.14M +24.8% Sep 28, 2014 Jan 3, 2015 10-K 2017-03-01
Q3 2014 $36.9M $9.46M +$1.44M +18% Jun 29, 2014 Sep 27, 2014 10-Q 2015-11-12
Q2 2014 $35.4M $10.1M -$2.08M -17.1% Mar 30, 2014 Jun 28, 2014 10-Q 2015-08-12
Q1 2014 $37.5M $8.71M -$47K -0.54% Dec 29, 2013 Mar 29, 2014 10-Q 2015-05-13
Q4 2013 $37.6M $8.62M -$1.08M -11.1% Sep 29, 2013 Dec 28, 2013 10-K 2016-03-01
Q3 2013 $38.6M $8.02M +$1.16M +16.8% Jun 30, 2013 Sep 28, 2013 10-Q 2014-11-06
Q2 2013 $37.5M $12.2M +$3.98M +48.6% Mar 31, 2013 Jun 29, 2013 10-Q 2014-08-05
Q1 2013 $33.5M $8.76M +$1.51M +20.9% Dec 30, 2012 Mar 30, 2013 10-Q 2014-05-07
Q4 2012 $32M $9.71M +$2.78M +40.1% Sep 30, 2012 Dec 29, 2012 10-K 2015-03-17
Q3 2012 $29.2M $6.86M +$337K +5.17% Jul 1, 2012 Sep 29, 2012 10-Q 2013-11-07
Q2 2012 $28.9M $8.18M +$886K +12.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $28M $7.24M +$1.27M +21.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q4 2011 $26.7M $6.93M Oct 2, 2011 Dec 31, 2011 10-K 2014-03-13
Q3 2011 $6.52M +$284K +4.55% Jul 3, 2011 Oct 1, 2011 10-Q 2012-11-07
Q2 2011 $7.3M +$1.59M +27.9% Apr 3, 2011 Jul 2, 2011 10-Q 2012-08-08
Q1 2011 $5.98M Jan 2, 2011 Apr 2, 2011 10-Q 2012-05-10
Q3 2010 $6.24M Jul 4, 2010 Oct 2, 2010 10-Q 2011-11-09
Q2 2010 $5.71M Apr 4, 2010 Jul 3, 2010 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.